The Board of Directors approved performance-based stock option grants for CEO Daniyel Erdberg and CFO Theresa Carlise. A total of 900,000 options were granted: 750,000 to the CEO and 150,000 to the CFO. Options have a five-year term expiring May 27, 2031, with an exercise price of $4.50 per share. Vesting is contingent upon the company achieving cumulative gross revenue milestones of $5M, $10M, $15M, $20M, and $25M. CFO Theresa Carlise received an amended employment agreement including a $1,000 monthly home office allowance and enhanced severance protections.